Publication & Citation Trends
Publications
93 total
The ACTION (AT1R and CCR2 Targets for Inflammatory Nephrosis) Program in Focal Segmental Glomerulosclerosis
Cited by 0
Semantic Scholar
POS-544 Atrasentan in Patients with Proteinuric Glomerular Diseases (The AFFINITY Study)
Cited by 1
Semantic Scholar
Interim Analysis of the EAGLE Trial: An Open-Label Study to Assess the Long-Term Safety and Tolerability of Bardoxolone Methyl in Patients with Alport Syndrome
Cited by 1
Semantic Scholar
P0189SODIUM ZIRCONIUM CYCLOSILICATE CORRECTS HYPERKALAEMIA WITHIN 72 HOURS AMONG OUTPATIENTS WITH SEVERE HYPERKALAEMIA (BASELINE SERUM POTASSIUM ≥6 MMOL/L) REGARDLESS OF RENAL FUNCTION LEVEL OR RAASI USE: POST HOC SUBGROUP ANALYSIS OF A PHASE 3 TRIAL OA
Cited by 0
Semantic Scholar
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study OA
Cited by 55
Semantic Scholar
P0198SODIUM ZIRCONIUM CYCLOSILICATE INCREASES SERUM BICARBONATE CONCENTRATIONS AMONG PATIENTS WITH HYPERKALAEMIA: RESULTS FROM THREE RANDOMIZED, MULTI-DOSE, PLACEBO CONTROLLED TRIALS
Cited by 0
Semantic Scholar
Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials OA
Cited by 26
Semantic Scholar
Erratum to: Sodium Zirconium Cyclosilicate Increases Serum Bicarbonate Concentrations Among Patients with Hyperkalaemia: Exploratory Analyses from Three Randomized, Multi-Dose, Placebo-Controlled Trials OA
Cited by 0
Semantic Scholar
Research Topics
Chronic Kidney Disease and Diabetes
(24)
Renal Diseases and Glomerulopathies
(24)
Potassium and Related Disorders
(21)
Blood Pressure and Hypertension Studies
(14)
Parathyroid Disorders and Treatments
(14)
Affiliations
Oregon State University
The Royal Melbourne Hospital
Bayer (United States)
University of Melbourne
Cornell University